Health By Lev Facher It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
First Opinion By Abraar Karan, Ranu Dhillon, and Devabhaktuni Srikrishna Along with vaccine rollouts, the U.S. needs a National Hi-Fi Mask Initiative
First Opinion By Karen Glanz and Holly Fernandez Lynch ‘Three Identical Strangers’: It’s not too late to address the ethical violations
First Opinion By Cara Kiernan Fallon and Jason Karlawish It’s time to change the definition of ‘health’
First Opinion By Stanley Plotkin, Norman Baylor, and Keona Jeane Wynne The U.S. needs a National Vaccine Day
First Opinion By Amir Kalali and Craig Lipset Decentralized clinical trials: Collaboration is needed to drive their adoption and impact
First Opinion By Nandita Murukutla and Rebecca Perl Governments’ alcohol subsidies are harmful to public health
First Opinion By Daniel Carpenter and Gregg Gonsalves The stakes for choosing the right FDA commissioner couldn’t be higher
Politics By Lev Facher Major health companies and trade groups suspend campaign contributions after Capitol riot
First Opinion By Melissa J. Perry Stop sidelining science. Bring back federal scientific advisory committees
First Opinion By Vineet Arora, Tricia Pendergrast, and Shikha Jain Doctors on social media are being cyberbullied and sexually harassed. It’s time to change that
Politics By Nicholas Florko Biden’s HHS pick, Becerra, has taken in more campaign cash from health groups than any other industry
First Opinion By David Tuller and Steven Lubet Proposed British guidelines reject useless chronic fatigue syndrome treatments
First Opinion By Kacie Kidd and Gina Sequeira Laws to ban gender-affirming care could increase youth suicides, parents fear
Politics By Lev Facher In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’
Politics By Nicholas Florko Amid Covid-19, tiny biotech companies are hiring lobbyists for the first time
First Opinion By Gunnar Esiason and Emma D'Agostino Health care conferences should embrace patients as collaborators
Politics By Lev Facher AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018
Exclusive By Nicholas Florko In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies
Politics By Lev Facher Many drug companies working on Covid-19 vaccines and treatments are lobbying harder than usual
Politics By Nicholas Florko PhRMA’s top communicator, a fierce defender of the industry, leaves for ExxonMobil
Exclusive By Nicholas Florko and Matthew Herper Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?
Politics By Lev Facher General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic
Politics By Nicholas Florko Congress’s coronavirus stimulus package contains plenty of unrelated wins for the health industry
First Opinion By Sarah Temkin When surgery becomes ‘women’s work’: the devaluation of gynecologic specialties